Valeo Pharma Inc.

TSX:VPH 주식 보고서

시가총액: CA$4.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Valeo Pharma 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Al Moghaddam

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기less than a year
CEO 소유권n/a
경영진 평균 재임 기간1.6yrs
이사회 평균 재임 기간1.8yrs

최근 관리 업데이트

Recent updates

Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Jun 14
Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Apr 20
Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Mar 02
Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Jan 17
Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Jun 08
Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Jun 24
Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Jun 17
Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

Feb 08
Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

CEO

Al Moghaddam (57 yo)

less than a year

테뉴어

Mr. Al Moghaddam, B. Com. CMA had been a Director at Valeo Pharma Inc. since March 21, 2024 until June 2024 and served as its Chief Development Officer since June 2024 until August 2024 and serves as its C...


리더십 팀

이름위치테뉴어보상소유권
Kyle Steiger
Senior VP & Chief Commercial Officer2.3yrsCA$388.21k0.020%
CA$ 872.5
Al Moghaddam
Chief Executive Officerless than a year데이터 없음데이터 없음
Pascal Tougas
Chief Financial Officerless than a year데이터 없음데이터 없음
Frédéric Dumais
Director of Communications & Investor Relationsno data데이터 없음데이터 없음
Guy-Paul Allard
VP of Legal Affairs & Corporate Secretaryno data데이터 없음0%
CA$ 0
Jean Fournier
Head of Ophthalmology Business Unit2.3yrs데이터 없음데이터 없음

1.6yrs

평균 재임 기간

경험이 풍부한 관리: VPH 의 관리팀은 경험 (평균 재직 기간 1.6 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Robert Raich
Independent Directorless than a year데이터 없음0.18%
CA$ 7.9k
Richard MacKay
Chairman of the Advisory Board & Director15.8yrs데이터 없음16.44%
CA$ 730.0k
Steven Saviuk
Chairman21.7yrsCA$466.29k0.18%
CA$ 8.1k
Marc Leger
Independent Non-Executive Director2.6yrs데이터 없음2.36%
CA$ 104.9k
Richard Lajoie
Independent Directorless than a year데이터 없음데이터 없음
Charles Bisaillon
Independent Directorless than a year데이터 없음데이터 없음

1.8yrs

평균 재임 기간

65yo

평균 연령

경험이 풍부한 이사회: VPH 의 이사회경험(평균 재직 기간 1.8 년)으로 간주되지 않으므로 새 이사회가 필요합니다.